Science Explorer Back to mapMap
Discussion
Company · Leusden · Netherlands

Mundipharma (Netherlands)

Research works
42
▲ 16% vs 2018-21
Citations
1.1k
25.9 per fractional work
Top-10% rate
10.7%
all institutions 10.0%
Open access
24%
world 40%
International
29%
world 18%

Not ranked overall: Mundipharma (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Mundipharma (Netherlands) work in?

In all years, 47% of research at Mundipharma (Netherlands) is in Health Sciences, 24% in Social Sciences. Its largest fields are Medicine (33%), Health Professions (14%), Engineering (14%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 20 fractional works · 47.1% of its workMedicine: 14 fractional works · 32.8% of its workSurgery: 2 fractional works · 4.7% of its workPulmonary and Respiratory Medicine: 2 fractional works · 3.7% of its workPsychiatry and Mental health: 1 fractional works · 2.6% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.2% of its workRheumatology: 1 fractional works · 1.8% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.7% of its workOphthalmology: 1 fractional works · 1.6% of its workInfectious Diseases: 1 fractional works · 1.5% of its workGenetics: 1 fractional works · 1.4% of its workGastroenterology: 1 fractional works · 1.3% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.2% of its workUrology: 0 fractional works · 1.2% of its workPhysiology: 0 fractional works · 1.1% of its workPathology and Forensic Medicine: 0 fractional works · 1.0% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.0% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.7% of its workPharmacology: 0 fractional works · 0.7% of its workOncology: 0 fractional works · 0.6% of its workGeriatrics and Gerontology: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.4% of its workObstetrics and Gynecology: 0 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.4% of its workEpidemiology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.7% of its workHealth Professions: 6 fractional works · 14.1% of its workGeneral Health Professions: 5 fractional works · 12.9% of its workComplementary and Manual Therapy: 0 fractional works · 1.2% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workSocial Sciences: 10 fractional works · 23.6% of its workSocial Sciences: 5 fractional works · 12.1% of its workSociology and Political Science: 2 fractional works · 4.2% of its workAnthropology: 1 fractional works · 3.3% of its workPolitical Science and International Relations: 1 fractional works · 2.6% of its workSafety Research: 0 fractional works · 0.8% of its workEducation: 0 fractional works · 0.4% of its workGeneral Social Sciences: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.5% of its workArts and Humanities: 3 fractional works · 6.9% of its workClassics: 1 fractional works · 2.4% of its workPhilosophy: 1 fractional works · 2.0% of its workReligious studies: 1 fractional works · 2.0% of its workHistory and Philosophy of Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 1 fractional works · 2.9% of its workEconomics and Econometrics: 1 fractional works · 2.1% of its workFinance: 0 fractional works · 0.8% of its workBusiness, Management and Accounting: 0 fractional works · 1.2% of its workStrategy and Management: 0 fractional works · 0.8% of its workAccounting: 0 fractional works · 0.4% of its workPsychology: 0 fractional works · 0.5% of its workSocial Psychology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 8 fractional works · 18.4% of its workEngineering: 6 fractional works · 13.7% of its workCivil and Structural Engineering: 3 fractional works · 6.7% of its workMechanical Engineering: 1 fractional works · 2.4% of its workBiomedical Engineering: 1 fractional works · 1.4% of its workAerospace Engineering: 0 fractional works · 0.8% of its workBuilding and Construction: 0 fractional works · 0.8% of its workControl and Systems Engineering: 0 fractional works · 0.8% of its workElectrical and Electronic Engineering: 0 fractional works · 0.8% of its workPhysics and Astronomy: 1 fractional works · 2.1% of its workAtomic and Molecular Physics, and Optics: 1 fractional works · 1.6% of its workCondensed Matter Physics: 0 fractional works · 0.2% of its workRadiation: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 1.2% of its workElectrochemistry: 0 fractional works · 0.8% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.4% of its workMaterials Science: 0 fractional works · 1.0% of its workMaterials Chemistry: 0 fractional works · 0.7% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.4% of its workEarth and Planetary Sciences: 0 fractional works · 0.3% of its workPaleontology: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.2% of its workLife Sciences: 5 fractional works · 10.9% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 4.4% of its workMolecular Biology: 1 fractional works · 2.3% of its workGenetics: 0 fractional works · 1.1% of its workCell Biology: 0 fractional works · 0.8% of its workCancer Research: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 2 fractional works · 3.8% of its workPlant Science: 1 fractional works · 1.7% of its workGeneral Agricultural and Biological Sciences: 1 fractional works · 1.6% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.5% of its workNeuroscience: 1 fractional works · 1.4% of its workCognitive Neuroscience: 1 fractional works · 1.4% of its workImmunology and Microbiology: 0 fractional works · 1.1% of its workImmunology: 0 fractional works · 1.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workALL ITS WORKMundipharma(Netherlands)42fractional works, all years
Life Sciences11%Physical Sciences18%Health Sciences47%Social Sciences24%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine1432.8%
    2. Health Professions614.1%
    3. Nursing00.3%
    1. Social Sciences512.1%
    2. Arts and Humanities36.9%
    3. Economics, Econometrics and Finance12.9%
    4. Business, Management and Accounting01.2%
    5. Psychology00.5%
    1. Engineering613.7%
    2. Physics and Astronomy12.1%
    3. Chemistry01.2%
    4. Materials Science01.0%
    5. Earth and Planetary Sciences00.3%
    6. Environmental Science00.2%
    1. Biochemistry, Genetics and Molecular Biology24.4%
    2. Agricultural and Biological Sciences23.8%
    3. Neuroscience11.4%
    4. Immunology and Microbiology01.1%
    5. Pharmacology, Toxicology and Pharmaceutics00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.55× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.63× its world share, 0 worksBiochemistry, Geneti…Neuroscience: 5.34× its world share, 0 worksNeuroscienceEarth and Planetary Sciences: 1.94× its world share, 0 worksEarth and Planetary …Engineering: 0.61× its world share, 0 worksEngineeringMaterials Science: 0.87× its world share, 0 worksMaterials ScienceHealth Professions: 2.24× its world share, 0 worksHealth ProfessionsMedicine: 0.85× its world share, 1 worksMedicineArts and Humanities: 9.47× its world share, 1 worksArts and HumanitiesPsychology: 1.20× its world share, 0 worksPsychologySocial Sciences: 0.54× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Arts and Humanities, 9.5×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Arts and Humanities9.47×1 works
  2. Neuroscience5.34×0 works
  3. Health Professions2.24×0 works
  4. Earth and Planetary Sciences1.94×0 works
  5. Biochemistry, Genetics and Molecular Biology1.63×0 works
  6. Agricultural and Biological Sciences1.55×0 works
  7. Psychology1.20×0 works
  8. Materials Science0.87×0 works
  9. Medicine0.85×1 works
  10. Engineering0.61×0 works
  11. Social Sciences0.54×0 works

Who are the top researchers at Mundipharma (Netherlands)?

Ranked on the quality score, Arndt Meinhold and Franz Alfred Schilder lead among researchers whose main affiliation is Mundipharma (Netherlands).

  1. 1 Arndt Meinhold Netherlands · #3,776,750 worldwide 73 citations · 23 works
  2. 2 Franz Alfred Schilder Netherlands · #5,202,401 worldwide 107 citations · 48 works
All ranked researchers at Mundipharma (Netherlands)

What are the most cited papers from Mundipharma (Netherlands)?

The most cited paper from Mundipharma (Netherlands) is "Corporate Innovations and Mergers and Acquisitions" (Jan Bena, Kai Li, 2013), with 927 citations. Next come "Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody–Drug Conjugate SYD985" (225) and "Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature" (192).

Most cited papers
#PaperReleasedCitations
1 Corporate Innovations and Mergers and Acquisitions Jan Bena, Kai Li · The Journal of Finance 13 May 2013 927
2 Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody–Drug Conjugate SYD985 Ronald C. Elgersma, Ruud G. E. Coumans, Tijl Huijbregts et al. · Molecular Pharmaceutics Open access 30 Jan 2015 225
3 Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature Robert J. Damstra, H. G. J. Voesten, W. Dick van Schelven et al. · Breast Cancer Research and Treatment 12 Feb 2008 192
4 Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults Luis Pérez de Llano et al. · American Journal of Respiratory and Critical Care Medicine Open access 3 May 2024 136
5 Uncoupling protein 3 as a mitochondrial fatty acid anion exporter Patrick Schrauwen, Joris Hoeks, Gert Schaart et al. · The FASEB Journal Open access 2 Oct 2003 124
All 47 most cited papers, with filters and sorting

Which keywords describe research at Mundipharma (Netherlands)?

By fractional works in all years, weighted toward what it does more of than the world: Public Health, Primary Care, Material Properties, Structural Health Monitoring, Construction, Inflammation, Violence and Classification.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Public Health5▲ 8.9×7 topics
  2. Inflammation3▲ 2.8×12 topics
  3. Primary Care2▲ 13×3 topics
  4. Globalization2▲ 2.5×5 topics
  5. Material Properties2▲ 36×2 topics
  6. Structural Health Monitoring2▲ 45×2 topics
  7. Construction2▲ 40×2 topics
  8. Sustainable Development2▲ 3.7×2 topics
  9. Genetics2▲ 5.0×6 topics
  10. Violence2▲ 28×2 topics
  11. Classification2▲ 9.6×3 topics
  12. Bridge Engineering1▲ 204×1 topic
  13. Civil Engineering1▲ 55×1 topic
  14. Conflict1▲ 23×1 topic
  15. Mortality1▲ 6.9×1 topic
  16. Chronic Diseases1▲ 10×2 topics
  17. Drug Resistance1▲ 9.0×2 topics
  18. Epidemiological Study1▲ 38×2 topics
  19. Historical Narratives1▲ 43×2 topics
  20. Community Health1▲ 19×2 topics
  21. Germany1▲ 87×1 topic
  22. Health Surveys1▲ 87×1 topic
  23. Healthcare Systems1▲ 38×2 topics
  24. Social Determinants of Health1▲ 12×2 topics
  25. Social Dynamics1▲ 38×2 topics
  26. Surgery1▲ 7.8×2 topics
  27. Advocacy1▲ 55×1 topic
  28. Ancient Rome1▲ 54×1 topic
  29. Antiepileptic Drugs1▲ 24×2 topics
  30. Criminal Law1▲ 27×1 topic
  31. Cultural History1▲ 17×1 topic
  32. Epilepsy1▲ 19×1 topic
  33. Greek Literature1▲ 54×1 topic
  34. Healthcare Policy1▲ 32×1 topic
  35. Inequalities1▲ 64×1 topic
  36. Iron Oxides1▲ 132×1 topic
  37. Medieval Literature1▲ 99×1 topic
  38. Neurobiology1▲ 7.4×2 topics
  39. Pediatrics1▲ 55×1 topic
  40. Seizures1▲ 32×1 topic

Which research topics does Mundipharma (Netherlands) publish most on?

By volume in 2022-now: Historical, Literary, and Cultural Studies, EEG and Brain-Computer Interfaces, Optimization and Mathematical Programming and Health and Conflict Studies.

  1. 1 Historical, Literary, and Cultural Studies Classics 1 works
  2. 2 EEG and Brain-Computer Interfaces Cognitive Neuroscience 0 works
  3. 3 Optimization and Mathematical Programming Control and Systems Engineering 0 works
  4. 4 Health and Conflict Studies General Health Professions 0 works
  5. 5 Protein purification and stability Molecular Biology 0 works
  6. 6 Leprosy Research and Treatment Infectious Diseases 0 works
  7. 7 Crystallization and Solubility Studies Materials Chemistry 0 works
  8. 8 Global Health and Surgery Public Health, Environmental and Occupational Health 0 works
  9. 9 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  10. 10 Scarabaeidae Beetle Taxonomy and Biogeography Paleontology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available24.5%not open75.5%

World: 40% of research is openly available.

with international co-authors28.7%domestic only71.3%

World: 18% is written across borders.

How has Mundipharma (Netherlands)'s research output changed?

Output in 2022-2025 was 16% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Mundipharma (Netherlands) as a percentage of every work published that year, 0.000023% in 2024.

still counting0.00020%0.00040%0.00060%Mundipharma (Netherlands)0.000017% in 202519801990200020102020

Fractional works of Mundipharma (Netherlands) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Leusden

All research institutions in Leusden

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Mundipharma (Netherlands). Posts are plain text and can be reported.